期刊文献+

骨化三醇对单侧输尿管梗阻大鼠肾小管上皮细胞转分化影响的研究

Effects of calcitriol on tubular epithelial myofibroblast transdifferentiation in rats with unilateral ureteral obstruction
暂未订购
导出
摘要 目的观察幼年大鼠单侧输尿管梗阻(UUO)肾组织中α-肌动蛋白(α-SMA)、E-钙黏蛋白(E-Cad)、转化生长因子-β1(TGF-β1)、骨形态发生蛋白-7(BMP-7)mRNA的表达,探讨骨化三醇对肾小管上皮细胞转分化(EMT)干预效应及机制。方法 54只雄性SD大鼠随机分为3组:假手术组(A组)、UUO模型组(B组)及UUO模型干预组(C组)各18只,灌胃满3、7、14d取肾。实时荧光定量聚合酶链反应(RT-PCR)法检测各组α-SMA、E-Cad、TGF-β1、BMP-7mRNA表达水平。结果与A组相比,B组E-Cad、BMP-7mRNA表达明显下降(P<0.01),α-SMA、TGF-β1mRNA表达显著增高(P<0.01);C组与B组相比,E-Cad、BMP-7mRNA表达明显上调(P<0.01),α-SMA、TGF-β1mRNA表达明显下降(P<0.01)。结论骨化三醇对UUO模型大鼠肾小管上皮细胞转分化有抑制作用,这种抑制作用可能与下调TGF-β的表达及上调BMP-7的表达有关。 Objective To determine the effects and potential mechanisms of calcitriol on tubular epithelial my- ofibroblast transdifferentiation (EMT) in young rats with unilateral ureteral obstruction (UUO), based on the expression of renal tubulointerstitial or-smooth muscle actin (α-SMA), E-cadherin (E-Cad), transforming growth factor-β1 (TGF-β1) and bone morphogenetic protein-7 (BMP-7) mRNA. Methods Fifty-four male Sprague-Dawley rats were randomly al- located into Sham group (group A, n=18), UUO model group (group B, n=18) and UUO treatment group (group C, n= 18). The renal tissue was biopsied at days 3, 7 and 14 for subsequent assays of α-SMA, E-Cad, TGF-β1 and BMP-7 mRNA expression by using real-time fluorescence quantitative polymerase chain reaction (RT-PCR). Results Com- pared with group A, significantly attenuated E-Cad and BMP-7 mRNA expression yet markedly increased α-SMA and TGF-β1 mRNA was noted in group B (all P〈0.01). Group C was characterized by considerably up-regulated E-Cad and BMP-7 mRNA expression yet down-regulated expression of α-SMA and TGF-β1 mRNA when compared with group B (all P〈0.01). Conclusion The fact that calcitriol suppresses EMT in rats with UUO may be associated with down- regulation of TGF-β1 mRNA expression and up-regulated expression of BMP-7 mRNA.
出处 《中国药物与临床》 CAS 2013年第4期443-446,共4页 Chinese Remedies & Clinics
基金 山西省高校科技研究开发基金(2003103)
关键词 骨化三醇 肾间质纤维化 输尿管梗阻 Calcitriol Renal interstitial fibrosis Ureteral obstruction
  • 相关文献

参考文献11

  • 1Kallui R,Neilson EG. Epithelial-mesenchymal transition and its implications for fibrosis. J Clin Invest,2003,112:1776-1784.
  • 2Matsui I,Hamano T,Tomida K,et al. Active vitamin D and its analogue,22-oxacalcitriol, ameliorate puromycin aminonucleo- side-induced nephrosis in rats. Nephrol Dial Transplant, 2009,24 (8) :2354-2361.
  • 3Hills CE,Siamantouras E,Smith SW,et al. TGF- modulates cell-to-cell communication in early epithelial-to-mesenehymal transition. Diabetologia,2012,55(3) :812-824.
  • 4Hills CE,Squires PE. The role of TGF-13 and epithelial-to-mes- enchymal transition in diabetic nephropathy. Cytokine Growth Factor Rev,2011,22(3) : 131-139.
  • 5Motazed R,Colville-Nash P,Kwan JT,et al. BMP-7 and proximal tubule epithelial cell: activation of multiple signaling pathways reveals a novel anti-fibrotie mechanism. Pharm Res,2008,25 (10) :2440-2446.
  • 6Nguyen TQ,Roestenberg P,Van Neiuwenhoven FA,et al. CTGF inhibits BMP-7 signaling in diabetic nephropathy. J Am Soc Nephrol, 2008,19 ( 11 ) :2098-2107.
  • 7Zeisberg M,Kalluri R. The role of epithelial-to-mesenehymal transition in renal fibrosis. Mol Med,2004,82(3) : 175-181.
  • 8Rodrguez-lturbe B, Garefa-Garcia G. The role of tubulointersti- tial inflammation in the progression of chronic renal failure. Nephron Clin Pract,2010,116(2) :81-88.
  • 9He W, Kang YS, Dai C, et al. Blockade of Wnt/[3-Catenin Signal- ing by pariealeitol Ameliorates Proteinuria and kidney injury. J Am Soe Nephrol, 2011,22( 1 ) : 90-103.
  • 10邹敏书,余健,周建华.活性维生素D及其类似物对足细胞的保护作用[J].临床儿科杂志,2012,30(1):93-96. 被引量:9

二级参考文献30

  • 1García-Canton C,Bosch E,Ramírez A,et al.Vascular calcifi-cation and 25-hydroxyvitamin D levels in non-dialysis patients with chronic kidney disease stages 4 and 5[J].Nephrol Dial Transplant,2011,26(7):2250-2256.
  • 2Drechsler C,Verduijn M,Pilz S,et al.Vitamin D status and clinical outcomes in incident dialysis patients:results from the NECOSAD study[J].Nephrol Dial Transplant,2011,26(3):1024-1032.
  • 3Pilz S,Tomaschitz A,Friedl C,et al.Vitamin D status and mortality in chronic kidney disease[J].Nephrol Dial Transplant,2011,26(11):3603-3609.
  • 4Mehrotra R,Kermah DA,Salusky IB,et al.Chronic kidney disease,hypovitaminosis D,and mortality in the United States[J].Kidney Int,2009,76(9):977-983.
  • 5Stubbs JR,Idiculla A,Slusser J,et al.Cholecalciferol supple-mentation alters calcitriol-responsive monocyte proteins and decreases inflammatory cytokines in ESRD[J].J Am Soc Nephrol,2010,21(2):353-361.
  • 6Agarwal R,Acharya M,Tian J,et al.Antiproteinuric effect of oral paricalcitol in chronic kidney disease[J].Kidney Int,2005,68(6):2823-2828.
  • 7Alborzi P,Patel NA,Peterson C,et al.Paricalcitol reduces albuminuria and inflammation in chronic kidney disease:a randomized double-blind pilot trial[J].Hypertension,2008,52(2):249-255.
  • 8de Zeeuw D,Agarwal R,Amdahl M,et al.Selective vitamin D receptor activation with paricalcitol for reduction of albuminuria in patients with type 2 diabetes (VITAL study):a randomised controlled trial[J].Lancet,2010,376(9752):1543-1551.
  • 9Stumpf WE,Sar M,Reid FA,et al.Target cells for 1,25-dihydroxyvitamin D3 in intestinal tract,stomach,kidney,skin,pituitary,and parathyroid[J].Science,1979,206(4423):1188-1190.
  • 10Yamauchi K,Takano Y,Kasai A,et al.Screening and identifi-cation of substances that regulate nephrin gene expression using engineered reporter podocytes[J].Kidney Int,2006,70(5):892-900.

共引文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部